MCID: GST014
MIFTS: 31

Gastrointestinal Lymphoma malady

Categories: Cancer diseases, Gastrointestinal diseases, Immune diseases

Aliases & Classifications for Gastrointestinal Lymphoma

Aliases & Descriptions for Gastrointestinal Lymphoma:

Name: Gastrointestinal Lymphoma 12 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:903
NCIt 47 C38162
SNOMED-CT 64 449072004
UMLS 69 C0740372

Summaries for Gastrointestinal Lymphoma

MalaCards based summary : Gastrointestinal Lymphoma is related to lymphoma and myotonic disease. An important gene associated with Gastrointestinal Lymphoma is NBN (Nibrin). The drugs Dexamethasone and Doxorubicin have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and colon, and related phenotype is nervous system.

Related Diseases for Gastrointestinal Lymphoma

Diseases related to Gastrointestinal Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 12)
id Related Disease Score Top Affiliating Genes
1 lymphoma 10.5
2 myotonic disease 9.8 CD5 PHYH
3 b-cell lymphomas 9.6
4 inflammatory bowel disease 9.6
5 heavy chain disease 9.6
6 diffuse large b-cell lymphoma 9.4
7 peripheral t-cell lymphoma 9.4
8 mucositis 9.4
9 sarcoma 9.4
10 amyloidosis 9.4
11 alpha-heavy chain disease 9.4
12 leishmaniasis 8.8 CD5 DPP6 GOLGB1 KCND2 MIB1 NBN

Graphical network of the top 20 diseases related to Gastrointestinal Lymphoma:



Diseases related to Gastrointestinal Lymphoma

Symptoms & Phenotypes for Gastrointestinal Lymphoma

MGI Mouse Phenotypes related to Gastrointestinal Lymphoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.1 CD5 DPP6 KCND2 MIB1 NBN PHYH

Drugs & Therapeutics for Gastrointestinal Lymphoma

Drugs for Gastrointestinal Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 503)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
2
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
3
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 65271-80-9 4212
4
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 20830-81-3 30323
5
Vinblastine Approved Phase 4,Phase 3,Phase 2 865-21-4 13342 241903
6
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
7
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
8
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
9
Idarubicin Approved Phase 4,Phase 3,Phase 2 58957-92-9 42890
10
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-94-4 6253
11
Teniposide Approved Phase 4,Phase 3,Phase 2 29767-20-2 34698
12
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
13
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 148-82-3 4053 460612
14
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
15
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
16
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
17
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
18
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
19
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3778-73-2 3690
20
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
21
Mechlorethamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-75-2 4033
22
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 6857599, 9887054 43805
23
Mesna Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 3375-50-6 598
24
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
25
Granisetron Approved, Investigational Phase 4,Phase 2 109889-09-0 3510
26
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
27
Tropisetron Approved, Investigational Phase 4 105826-92-4, 89565-68-4 5595
28
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
29
Aprepitant Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 170729-80-3 151165 6918365
30
Palonosetron Approved, Investigational Phase 4,Phase 2 135729-61-2, 119904-90-4, 135729-56-5 148211
31
Cladribine Approved, Investigational Phase 4,Phase 1 4291-63-8 20279
32
Thioguanine Approved Phase 4,Phase 3,Phase 2,Phase 1 154-42-7 2723601
33
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
34
Fosaprepitant Approved Phase 4,Phase 2,Phase 1,Early Phase 1 172673-20-0 219090
35
Vindesine Approved Phase 4,Phase 3,Phase 2 59917-39-4, 53643-48-4 40839
36
Epirubicin Approved Phase 4,Phase 3,Phase 2 56420-45-2 41867
37
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
38
Asparaginase Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9015-68-3
39
Pegaspargase Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 130167-69-0
40
Dasatinib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 302962-49-8 3062316
41
Infliximab Approved Phase 4 170277-31-3
42
Metronidazole Approved Phase 4,Phase 2 443-48-1 4173
43
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 1 161796-78-7, 119141-88-7 4594 9579578
44
Azathioprine Approved Phase 4 446-86-6 2265
45
Lansoprazole Approved, Investigational Phase 4,Phase 2 103577-45-3 3883
46
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
47
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
48
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
49
Pirarubicin Investigational Phase 4,Phase 2 72496-41-4
50
Butyric Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1 107-92-6 264

Interventional clinical trials:

(show top 50) (show all 703)
id Name Status NCT ID Phase
1 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Unknown status NCT00274885 Phase 4
2 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Unknown status NCT02347878 Phase 4
3 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4
4 German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Unknown status NCT00198978 Phase 4
5 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. Completed NCT00440817 Phase 4
6 German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults Completed NCT00199017 Phase 4
7 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4
8 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4
9 AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Completed NCT00415103 Phase 4
10 Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia Completed NCT01358253 Phase 4
11 Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia Completed NCT00411541 Phase 4
12 Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia Completed NCT00199095 Phase 4
13 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93) Completed NCT00199069 Phase 4
14 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) Completed NCT00199056 Phase 4
15 Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab Completed NCT00199004 Phase 4
16 LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive Completed NCT00526305 Phase 4
17 Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma Recruiting NCT01088750 Phase 4
18 Treatment of Natural Killer/T Cell Lymphoma-I/II Recruiting NCT01501136 Phase 4
19 Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ Recruiting NCT01501149 Phase 4
20 Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas Recruiting NCT03071822 Phase 4
21 A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) Recruiting NCT01804166 Phase 4
22 EDOCH Alternating With DHAP for New Diagnosed Younger MCL Recruiting NCT02858804 Phase 4
23 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Recruiting NCT01746992 Phase 4
24 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Recruiting NCT02533700 Phase 4
25 Thiopurine Induced Pancreatitis in IBD Patients Recruiting NCT02281799 Phase 4
26 Intraluminal Therapy for Helicobacter Pylori Infection Recruiting NCT03124420 Phase 4
27 Rituximab (RTX) Therapy in Patients With Active TAO Recruiting NCT02378298 Phase 4
28 PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years Recruiting NCT01358201 Phase 4
29 Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study Recruiting NCT02894645 Phase 4
30 Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS Recruiting NCT01540812 Phase 4
31 The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia Recruiting NCT00846703 Phase 4
32 A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation Active, not recruiting NCT02576327 Phase 4
33 Treatment of High Risk Adult Acute Lymphoblastic Leukemia Active, not recruiting NCT00853008 Phase 4
34 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection Not yet recruiting NCT02959255 Phase 4
35 Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL) Not yet recruiting NCT03083951 Phase 4
36 High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection Not yet recruiting NCT02553083 Phase 4
37 Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Not yet recruiting NCT02690922 Phase 4
38 Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome Terminated NCT01625455 Phase 4
39 Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach Unknown status NCT00003617 Phase 3
40 Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma Unknown status NCT00016887 Phase 3
41 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma Unknown status NCT00006250 Phase 3
42 Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003639 Phase 3
43 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3
44 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3
45 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003650 Phase 3
46 Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma Unknown status NCT00025636 Phase 3
47 A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients Unknown status NCT01303887 Phase 3
48 Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma Unknown status NCT00678327 Phase 3
49 Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma Unknown status NCT00003728 Phase 3
50 Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL Unknown status NCT00209222 Phase 3

Search NIH Clinical Center for Gastrointestinal Lymphoma

Genetic Tests for Gastrointestinal Lymphoma

Anatomical Context for Gastrointestinal Lymphoma

MalaCards organs/tissues related to Gastrointestinal Lymphoma:

39
B Cells, T Cells, Colon

Publications for Gastrointestinal Lymphoma

Articles related to Gastrointestinal Lymphoma:

(show top 50) (show all 134)
id Title Authors Year
1
Gastrointestinal Lymphoma: Radiologic-Pathologic Correlation. ( 27265607 )
2016
2
Gastrointestinal lymphoma in Western Algeria: pattern of distribution and histological subtypes (retrospective study). ( 28078126 )
2016
3
The value of EUS in combination with cytological, flow cytometry, and gene rearrangement in the diagnosis of gastrointestinal lymphoma. ( 27139890 )
2016
4
A retrospective evaluation of lomustine (CeeNU) in 32 treatment naA^ve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013). ( 27277825 )
2016
5
Transcatheter Arterial Embolization for Gastrointestinal Bleeding Secondary to Gastrointestinal Lymphoma. ( 27435580 )
2016
6
Radiological Features of Gastrointestinal Lymphoma. ( 26819598 )
2016
7
Gastrointestinal Lymphoma in Southwest China: Subtype Distribution of 1,010 Cases Using the WHO (2008) Classification in a Single Institution. ( 26303279 )
2016
8
Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma. ( 26988370 )
2016
9
Feline discrete high-grade gastrointestinal lymphoma treated with surgical resection and adjuvant CHOP-based chemotherapy: retrospective study of 20 cases. ( 26333999 )
2015
10
Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients. ( 26632732 )
2015
11
TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma. ( 26214635 )
2015
12
Primary extranodal gastrointestinal lymphoma: a single center experience from southern Iran - report of changing epidemiology. ( 25204482 )
2014
13
From the radiologic pathology archives: gastrointestinal lymphoma: radiologic and pathologic findings. ( 25384294 )
2014
14
Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China. ( 24966993 )
2014
15
Gastrointestinal lymphoma: recent advances in diagnosis and treatment. ( 23635497 )
2013
16
Primary gastrointestinal lymphoma in an Egyptian district: a study using a population-based cancer registry. ( 23719408 )
2013
17
Endoscopic appearance of AIDS-related gastrointestinal lymphoma with c-MYC rearrangements: case report and literature review. ( 23922484 )
2013
18
Imaging of primary gastrointestinal lymphoma. ( 24332207 )
2013
19
Sonographic features of gastrointestinal lymphoma in 15 dogs. ( 23888986 )
2013
20
Expression of the Bcl-2 apoptotic marker in cats diagnosed with inflammatory bowel disease and gastrointestinal lymphoma. ( 22710860 )
2012
21
Primary gastrointestinal lymphoma. ( 23626617 )
2012
22
Feline gastrointestinal lymphoma: mucosal architecture, immunophenotype, and molecular clonality. ( 21505197 )
2012
23
Gastrointestinal lymphoma: a spectrum of fluoroscopic and CT findings. ( 20725903 )
2011
24
Primary pediatric gastrointestinal lymphoma. ( 22174497 )
2011
25
Abdominal irradiation as a rescue therapy for feline gastrointestinal lymphoma: a retrospective study of 11 cats (2001-2008). ( 21216169 )
2011
26
Primary gastrointestinal lymphoma. ( 21390139 )
2011
27
Diagnosis and staging in gastrointestinal lymphoma. ( 20206103 )
2010
28
Double-balloon endoscopy depicts diminutive small bowel lesions in gastrointestinal lymphoma. ( 19241169 )
2010
29
Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs. ( 19192147 )
2009
30
Surgery does not adversely affect survival in primary gastrointestinal lymphoma. ( 19399785 )
2009
31
Diagnosis and treatment of 81 patients with primary gastrointestinal lymphoma. ( 19648667 )
2009
32
Composite gastrointestinal lymphoma consisting of diffuse large B-cell lymphoma and peripheral T-cell lymphoma. ( 19588220 )
2009
33
Immunophenotypic and histologic classification of 50 cases of feline gastrointestinal lymphoma. ( 19261637 )
2009
34
The association of HTLV-1 infection, persistent intestinal infection with Strongyloides stercoralis and gastrointestinal lymphoma. ( 21686837 )
2009
35
Compressibility of gastrointestinal tract tumors during transabdominal sonographic examination: a clue to the diagnosis of gastrointestinal lymphoma. ( 17663459 )
2008
36
Imaging of gastrointestinal lymphoma. ( 18619382 )
2008
37
What to do when you suspect gastrointestinal lymphoma: a pathologist's perspective. ( 17336592 )
2007
38
Absence of CASP7 and CASP8 mutation in gastrointestinal lymphomas. ( 17532763 )
2007
39
Primary gastrointestinal lymphoma--a clinicopathologic study. ( 17883049 )
2007
40
Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. ( 17848697 )
2007
41
Clinical outcomes of 30 cases (1997-2004) of canine gastrointestinal lymphoma. ( 17975213 )
2007
42
Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. ( 16998789 )
2006
43
Primary gastrointestinal lymphoma of the colon. ( 16266930 )
2005
44
Clinico-pathological features and outcome of management of pediatric gastrointestinal lymphoma. ( 17102814 )
2005
45
Gastrointestinal lymphoma: where morphology meets molecular biology. ( 15643667 )
2005
46
Investigation of T-cell receptor-gamma gene rearrangement in gastrointestinal lymphomas by PCR-SSCP analysis. ( 15052681 )
2004
47
Gastrointestinal lymphoma in Thailand: a clinicopathologic analysis of 120 cases at Siriraj Hospital according to WHO classification. ( 15916100 )
2004
48
Characterization of lymphocytes in canine gastrointestinal lymphoma. ( 15017027 )
2004
49
Feline gastrointestinal lymphoma. ( 14552162 )
2003
50
Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. ( 12733145 )
2003

Variations for Gastrointestinal Lymphoma

Expression for Gastrointestinal Lymphoma

Search GEO for disease gene expression data for Gastrointestinal Lymphoma.

Pathways for Gastrointestinal Lymphoma

GO Terms for Gastrointestinal Lymphoma

Cellular components related to Gastrointestinal Lymphoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 voltage-gated potassium channel complex GO:0008076 8.62 DPP6 KCND2

Sources for Gastrointestinal Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....